cytarabine and pd 98059

cytarabine has been researched along with pd 98059 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bittman, R; Dent, P; Erukulla, RK; Fornari, FA; Grant, S; Jarvis, WD; Schwartz, GK; Tombes, RM	1
Andreeff, M; Carter, BZ; Estey, E; Estrov, Z; Harris, D; Konopleva, M; Kornblau, SM; Lapillonne, H; Milella, M; Zhao, S	1

Other Studies

2 other study(ies) available for cytarabine and pd 98059

Article	Year
Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling. Molecular pharmacology, 1998, Volume: 54, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bryostatins; Calcium-Calmodulin-Dependent Protein Kinases; Cytarabine; Diglycerides; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HL-60 Cells; Humans; Lactones; Macrolides; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction; Sphingosine; Stereoisomerism	1998
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. The Journal of clinical investigation, 2001, Volume: 108, Issue:6 Topics: Apoptosis; Benzamides; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; Enzyme Inhibitors; Flavonoids; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Proteins; X-Linked Inhibitor of Apoptosis Protein	2001

Article

Year

Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.

Molecular pharmacology, 1998, Volume: 54, Issue:5

Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bryostatins; Calcium-Calmodulin-Dependent Protein Kinases; Cytarabine; Diglycerides; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HL-60 Cells; Humans; Lactones; Macrolides; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction; Sphingosine; Stereoisomerism

1998

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

The Journal of clinical investigation, 2001, Volume: 108, Issue:6

Topics: Apoptosis; Benzamides; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; Enzyme Inhibitors; Flavonoids; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Proteins; X-Linked Inhibitor of Apoptosis Protein

2001